Evidence map›Paper›PMID 36543765›Full record

ArticleNature communications2022

Author Correction: A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer.

Manijeh Goldberg, Aaron Manzi, Amritpreet Birdi, Brandon Laporte, Peter Conway, Stefanie Cantin, Vasudha Mishra, Alka Singh, Alexander T Pearson, Eric R Goldberg and 21 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 12 institutions in 3 countries.

Manijeh Goldberg *David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. mgoldberg@privotechnologies.com.ORCID http://orcid.org/0000-0002-6134-8161
Aaron Manzi *David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.
Amritpreet BirdiPrivo Technologies, Peabody, MA, USA.
Brandon LaportePrivo Technologies, Peabody, MA, USA.
Peter ConwayPrivo Technologies, Peabody, MA, USA.
Stefanie CantinPrivo Technologies, Peabody, MA, USA.
Vasudha MishraDepartment of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA.
Alka SinghDepartment of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA.
Alexander T PearsonDepartment of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0003-2801-7456
Eric R GoldbergPrivo Technologies, Peabody, MA, USA.
Sam GoldbergerPrivo Technologies, Peabody, MA, USA.
Benjamin FlaumPrivo Technologies, Peabody, MA, USA.
Rifat HasinaDepartment of Surgery, Section of Otolaryngology-Head and Neck Surgery, University of Chicago, Chicago, IL, USA.
Nyall R LondonDepartment of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Gary L GalliaDepartment of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Chetan BettegowdaDepartment of Neurosurgery and Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-9991-7123
Simon YoungDepartment of Oral Maxillofacial Surgery, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Vlad SandulacheDepartment of Otolaryngology-Head & Neck Surgery, Baylor College of Medicine, Houston, TX, USA.
James MelvilleDepartment of Oral Maxillofacial Surgery, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Jonathan ShunDepartment of Oral Maxillofacial Surgery, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Sonya E O'NeillHarvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, USA.
Erkin AydinDavid H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-7811-2959
Alex ZhavoronkovInsilico Medicine, Pak Shek Kok, Hong Kong.ORCID http://orcid.org/0000-0001-7067-8966
Anxo VidalDepartment of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Galicia, Spain.ORCID http://orcid.org/0000-0002-0866-4202
Atenea SotoDepartment of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Galicia, Spain.
Maria Jose AlonsoDepartment of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Galicia, Spain.
Ari J RosenbergDepartment of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA.
Mark W LingenDepartment of Pathology, University of Chicago, Chicago, IL, USA.
Anil D'CruzDepartment of Oncology, Apollo Hospital, Mumbai, India.
Nishant AgrawalDepartment of Surgery, Section of Otolaryngology-Head and Neck Surgery, University of Chicago, Chicago, IL, USA. nagrawal@surgery.bsd.uchicago.edu.ORCID http://orcid.org/0000-0002-1361-3231
Evgeny IzumchenkoDepartment of Medicine, Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA. izumchen@uchicago.edu.ORCID http://orcid.org/0000-0003-3500-5664
Privo Technologies (United States) · USUniversity of Chicago · USJohns Hopkins University · USThe University of Texas Health Science Center at Houston · USUniversidade de Santiago de Compostela · ESApollo Hospitals · INBaylor College of Medicine · USMACOM (United States) · USMassachusetts College of Pharmacy and Health Sciences · USMassachusetts Institute of Technology · USUniversity of Illinois Chicago · USUniversity of Massachusetts Lowell · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36543765
PMCPMC9772340
OpenAlexW4312128792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.